Basit öğe kaydını göster

dc.contributor.authorBaccioglu, Ayse
dc.contributor.authorBavbek, Sevim
dc.date.accessioned2021-01-14T18:10:56Z
dc.date.available2021-01-14T18:10:56Z
dc.date.issued2020
dc.identifier.citationBaççıoğlu, A., & Bavbek, S. (2020). Asthma as A Comorbid Disease in COVID-19. Asthma Allergy Immunology. 18(1), 1-7.en_US
dc.identifier.issn1308-9234
dc.identifier.urihttps://doi.org/10.21911/aai.565
dc.identifier.urihttps://hdl.handle.net/20.500.12587/12830
dc.descriptionBavbek, Sevim/0000-0002-7884-0830en_US
dc.descriptionWOS:000592369300002en_US
dc.description.abstractSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 2019 (COVID-19). In terms of asthma and COVID-19, there is also a risk of experiencing an asthma exacerbation triggered by coronavirus infection beyond the direct risk of the infection itself. As a comorbid disease, the prevalence of COVID-19 infection in asthma patients is not clear. In addition, the influence of asthma on the severity of COVID-19 has not been reported. The aim of this review was to summarize the reported worldwide data about the prevalence and the clinical characteristics of patients with asthma during COVID-19 infection.en_US
dc.language.isoengen_US
dc.publisherBILIMSEL TIP YAYINEVIen_US
dc.relation.isversionof10.21911/aai.565en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAsthmaen_US
dc.subjectsevere asthmaen_US
dc.subjectasthma attacken_US
dc.subjectviral infectionen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.titleAsthma as a Comorbid Disease in COVID-19en_US
dc.typereviewen_US
dc.contributor.departmentKKÜen_US
dc.identifier.volume18en_US
dc.identifier.startpage1en_US
dc.identifier.endpage7en_US
dc.relation.journalASTIM ALLERJI IMMUNOLOJIen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster